Search This Blog

Monday, September 23, 2019

AstraZeneca spinoff Viela Bio sets IPO terms

Viela Bio (VIE) will offer 7.5M common shares at $19 – 21 in its IPO. Underwriters over-allotment will be an additional ~1.1M shares.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)